Anti‐fibrotic activity of Euglena gracilis and paramylon in a mouse model of non‐alcoholic steatohepatitis

Progression to non‐alcoholic steatohepatitis (NASH) manifests as hepatitis, fibrosis, and sometimes carcinoma, resulting in liver failure. Various clinical trials have indicated that several pharmacological agents, including angiotensin II receptor blockers (ARBs) or farnesoid X receptor (FXR) agoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakashima, Ayaka, Sugimoto, Ryota, Suzuki, Kengo, Shirakata, Yuka, Hashiguchi, Taishi, Yoshida, Chikara, Nakano, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341149/
https://www.ncbi.nlm.nih.gov/pubmed/30680167
http://dx.doi.org/10.1002/fsn3.828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341149/
https://www.ncbi.nlm.nih.gov/pubmed/30680167
http://dx.doi.org/10.1002/fsn3.828

Ejemplares similares